[Federal Register Volume 67, Number 160 (Monday, August 19, 2002)]
[Notices]
[Pages 53811-53812]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-20998]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 27, 2002, and published in the Federal 
Register on April 10, 2002, (67 FR 17470), Organix Inc., 240 Salem 
Street, Woburn, Massachusetts 01801, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as

[[Page 53812]]

a bulk manufacturer of cocaine (9041), a basic class of controlled 
substance listed in Schedule II.
    The firm plans to manufacture a derivative of cocaine in gram 
quantities for validation of synthetic procedures.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Organix, Inc. to manufacture is 
consistent with the public interest at this time. DEA has investigated 
Organix, Inc. to ensure that the company's registration is consistent 
with the public interest. This investigation included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 823 
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office 
of Diversion Control, hereby orders that the application submitted by 
the above firm for registration as a bulk manufacturer of the basic 
class of controlled substance listed above is granted.

    Dated: July 29, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-20998 Filed 8-16-02; 8:45 am]
BILLING CODE 4410-09-M